A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of HRS-2129 and the Food Effect on Pharmacokinetics Following Single Dose Administration in Healthy Subjects
Latest Information Update: 29 Oct 2024
At a glance
- Drugs HRS 2129 (Primary)
- Indications Pain
- Focus Adverse reactions
- Sponsors Shandong Suncadia Medicine
- 26 Oct 2024 Status changed from not yet recruiting to recruiting.
- 08 Oct 2024 New trial record